Adriadox 50mg Injection
Adriadox 50mg Injection

Adriadox 50mg Injection

MOQ : 100 Boxes

Adriadox 50mg Injection Specification

  • Indication
  • Breast cancer, Leukemia, Bone cancer, Ovarian cancer, Hodgkins lymphoma, Soft Tissue Sarcoma, Lung small cell carcinoma, Thyroid cancer, Thymoma
  • Salt Composition
  • Doxorubicin Hydrochloride (50mg)
  • Dosage Form
  • Injection
  • Feature
  • Single use, Preservative free, Sterile
  • Ingredients
  • Doxorubicin Hydrochloride, Excipients
  • Application
  • Ph Level
  • pH 2.5 to 3.5
  • Physical Color/Texture
  • Red solution, clear
  • Fermentation Smell
  • Odorless
  • Storage Instructions
  • Store at 2C - 8C. Do not freeze. Protect from light.
  • Shelf Life
  • 24 months
  • Strength
  • 50mg/vial
  • Molecular Formula
  • C27H29NO11.HCl
  • Administration Precautions
  • For use under medical supervision; avoid extravasation
  • Route of Administration
  • Intravenous Injection
  • Hazardous Drug
  • Yes
  • ATC Code
  • L01DB01
  • Molecular Weight
  • 579.98 g/mol
  • Therapeutic Class
  • Cytotoxic Chemotherapy
  • Brand Name
  • Adriadox 50mg
  • Prescription/Non Prescription
  • Prescription Only
  • Packaging Type
  • Glass Vial
 

Adriadox 50mg Injection Trade Information

  • Minimum Order Quantity
  • 100 Boxes
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 5000 Boxes Per Month
  • Delivery Time
  • 2-10 Days
  • Main Domestic Market
  • All India
 

About Adriadox 50mg Injection



Adriadox 50mg Injection stands as an extraordinary, ephemeral solution reserved for the exclusive care of individuals battling complex cancers. Famed for its efficacy, the towering formulation contains Doxorubicin Hydrochloride (50mg), with a molecular formula C27H29NO11.HCl, and a molecular weight of 579.98 g/mol. Delivered via intravenous injection in a sterile glass vial, it brings hope against breast cancer, leukemia, ovarian cancer, and more. This prescription-only, cytotoxic chemotherapeutic is single-use, preservative-free, and must be carefully administered by healthcare professionals, underlined by its hazardous profile.

Precise Usage and Specialized Applications

Adriadox 50mg Injection is intended for exclusive hospital and clinical settings, requiring administration by qualified professionals. It targets a broad spectrum of malignancies, including breast, bone, ovarian, and thyroid cancers, as well as Hodgkin's lymphoma and soft tissue sarcomas. This antineoplastic agent, unmistakable in its clear red solution, is administered intravenously, maximizing therapeutic impact as part of comprehensive chemotherapy protocols. Always reserve its use for scenarios demanding stringent supervision and adherence to administration precautions.


Sample Availability and Efficient Export Procedures

Sample requests for Adriadox 50mg Injection are considered under a clear policy aimed at fostering trust in international export markets. Compliance with logistics norms ensures all samples reach clients efficiently, leveraging secure transportation and careful packaging to maintain product integrity. Payment terms are tailored to suit diverse market needs, while a responsive support team streamlines the ordering process. Our commitment extends from seamless sample provision to the utmost reliability in every export shipment.


FAQ's of Adriadox 50mg Injection:


Q: How is Adriadox 50mg Injection administered?

A: Adriadox 50mg Injection is administered strictly as an intravenous injection by qualified medical professionals to ensure safe and effective delivery.

Q: What precautions should be taken during the administration process?

A: Adriadox 50mg must be used under medical supervision, with special care to avoid extravasation and to adhere to handling guidelines for hazardous drugs.

Q: When is Adriadox 50mg Injection typically prescribed?

A: This medication is prescribed for various cancers such as breast cancer, leukemia, ovarian cancer, and Hodgkin's lymphoma, based on clinical evaluation.

Q: Where should Adriadox 50mg Injection be stored?

A: Adriadox 50mg Injection should be stored at 2C - 8C, protected from light, and must not be frozen to maintain product stability.

Q: What are the benefits of using Adriadox 50mg Injection in oncology treatment?

A: It offers targeted cytotoxic action against a wide range of cancers, supporting advanced chemotherapy protocols, and may enhance treatment outcomes when used correctly.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Drugs Category

Arimizole Tablet

Arimizole Tablet

Minimum Order Quantity : 100 Boxes

Feature : Other, Highly selective nonsteroidal aromatase inhibitor

Application : Other, Oral administration as prescribed by a physician

Shelf Life : 24 months

Ingredients : Other , Anastrozole, Excipients

Dosage Form : Tablet

Canplatin 50mg 50ml Injection

Canplatin 50mg 50ml Injection

Minimum Order Quantity : 100 Boxes

Feature : Other, Sterile, singleuse, readytouse vial

Application : Other, Anticancer chemotherapy agent

Shelf Life : 18 months

Ingredients : Other , Cisplatin, Sodium Chloride, Water for Injection

Dosage Form : Injection

Adriadox 10mg Injection

Adriadox 10mg Injection

Minimum Order Quantity : 100 Boxes

Feature : Other, Readytouse, Controlled dosage, Antineoplastic agent

Application : Other, IV administration for oncology patients

Shelf Life : 24 months

Ingredients : Other , Doxorubicin Hydrochloride, Water for Injection, Excipients

Dosage Form : Injection

Methotrex 500MG Injection

Methotrex 500MG Injection

Minimum Order Quantity : 100 Boxes

Feature : Other, Cytotoxic, for intravenous use only

Application : Other, Antineoplastic and immunosuppressant therapy

Shelf Life : 2 years

Ingredients : Other , Methotrexate Sodium, Water for Injection

Dosage Form : Injection



Back to top